BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12767222)

  • 21. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
    Müller B; Daecke J; Fackler OT; Dittmar MT; Zentgraf H; Kräusslich HG
    J Virol; 2004 Oct; 78(19):10803-13. PubMed ID: 15367647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crosslink analysis of N-terminal, C-terminal, and N/B determining regions of the Moloney murine leukemia virus capsid protein.
    McDermott J; Karanjia S; Love Z; Barklis E
    Virology; 2000 Mar; 269(1):190-200. PubMed ID: 10725211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.
    Spearman P; Horton R; Ratner L; Kuli-Zade I
    J Virol; 1997 Sep; 71(9):6582-92. PubMed ID: 9261380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of human immunodeficiency virus type 1 Gag expression by a gp41 cytoplasmic domain fusion protein.
    Chan WE; Chen SS
    Virology; 2006 May; 348(2):418-29. PubMed ID: 16472834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly sensitive analysis of the interaction between HIV-1 Gag and phosphoinositide derivatives based on surface plasmon resonance.
    Anraku K; Fukuda R; Takamune N; Misumi S; Okamoto Y; Otsuka M; Fujita M
    Biochemistry; 2010 Jun; 49(25):5109-16. PubMed ID: 20496925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions.
    Perez-Caballero D; Hatziioannou T; Martin-Serrano J; Bieniasz PD
    J Virol; 2004 Sep; 78(17):9560-3. PubMed ID: 15308748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retroviral matrix domains share electrostatic homology: models for membrane binding function throughout the viral life cycle.
    Murray PS; Li Z; Wang J; Tang CL; Honig B; Murray D
    Structure; 2005 Oct; 13(10):1521-31. PubMed ID: 16216583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 3-O-(3',3'-dimethylsuccinyl) derivative of betulinic acid (DSB) inhibits the assembly of virus-like particles in HIV-1 Gag precursor-expressing cells.
    DaFonseca S; Blommaert A; Coric P; Hong SS; Bouaziz S; Boulanger P
    Antivir Ther; 2007; 12(8):1185-203. PubMed ID: 18240859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The host protein Staufen1 participates in human immunodeficiency virus type 1 assembly in live cells by influencing pr55Gag multimerization.
    Chatel-Chaix L; Abrahamyan L; Fréchina C; Mouland AJ; DesGroseillers L
    J Virol; 2007 Jun; 81(12):6216-30. PubMed ID: 17428849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catalysis and binding of cyclophilin A with different HIV-1 capsid constructs.
    Bosco DA; Kern D
    Biochemistry; 2004 May; 43(20):6110-9. PubMed ID: 15147195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo homodimerisation of HTLV-1 Gag and MA gives clues to the retroviral capsid and TM envelope protein arrangement.
    Rayne F; Kajava AV; Lalanne J; Mamoun RZ
    J Mol Biol; 2004 Oct; 343(4):903-16. PubMed ID: 15476809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.
    Lee PP; Linial ML
    J Virol; 1994 Oct; 68(10):6644-54. PubMed ID: 7521919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opposing effects of the M368A point mutation and deletion of the SP1 region on membrane binding of human immunodeficiency virus type 1 Gag.
    Guo X; Liang C
    Virology; 2005 May; 335(2):232-41. PubMed ID: 15840522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation of the SP1 sequence impairs both multimerization and membrane-binding activities of human immunodeficiency virus type 1 Gag.
    Guo X; Roldan A; Hu J; Wainberg MA; Liang C
    J Virol; 2005 Feb; 79(3):1803-12. PubMed ID: 15650204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional relationship between the matrix proteins of feline and simian immunodeficiency viruses.
    Manrique ML; González SA; Affranchino JL
    Virology; 2004 Nov; 329(1):157-67. PubMed ID: 15476883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor.
    Ternois F; Sticht J; Duquerroy S; Kräusslich HG; Rey FA
    Nat Struct Mol Biol; 2005 Aug; 12(8):678-82. PubMed ID: 16041386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
    Sugahara D; Tsuji-Kawahara S; Miyazawa M
    J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly.
    Dong X; Li H; Derdowski A; Ding L; Burnett A; Chen X; Peters TR; Dermody TS; Woodruff E; Wang JJ; Spearman P
    Cell; 2005 Mar; 120(5):663-74. PubMed ID: 15766529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in the alpha-helix directly C-terminal to the major homology region of human immunodeficiency virus type 1 capsid protein disrupt Gag multimerization and markedly impair virus particle production.
    Chu HH; Chang YF; Wang CT
    J Biomed Sci; 2006 Sep; 13(5):645-56. PubMed ID: 16770689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The N-terminal basic domain of the HIV-1 matrix protein does not contain a conventional nuclear localization sequence but is required for DNA binding and protein self-association.
    Hearps AC; Wagstaff KM; Piller SC; Jans DA
    Biochemistry; 2008 Feb; 47(7):2199-210. PubMed ID: 18225865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.